Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO

Diacerein is a symptomatic slow-acting drug in osteoarthritis (SYSADOA) with anti-inflammatory, anti-catabolic and pro-anabolic properties on cartilage and synovial membrane. It has also recently been shown to have protective effects against subchondral bone remodelling. Following the end of the rev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drugs Aging
Hauptverfasser: Pavelka, Karel, Bruyère, Olivier, Cooper, Cyrus, Kanis, John A., Leeb, Burkhard F., Maheu, Emmanuel, Martel-Pelletier, Johanne, Monfort, Jordi, Pelletier, Jean-Pierre, Rizzoli, René, Reginster, Jean-Yves
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer International Publishing 2016
Schlagworte:
Current Opinion
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4756045/
https://ncbi.nlm.nih.gov/pubmed/26849131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-016-0347-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge